Gleevec (Imatinib): Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

25 March 2024

24 March 2024

  • curprev 05:2305:23, 24 March 2024‎ Lazy talk contribs‎ 1,366 bytes +1,366‎ Created page with "{{TreatmentInfo |drug_name=Gleevec (Imatinib) |FDA_approval=Yes (for chronic myelogenous leukemia and other cancers, not specifically approved for gliomas) |used_for=Investigational use in gliomas, specifically targeting overexpression of platelet-derived growth factor receptor (PDGFR) |clinical_trial_phase=Exploratory/Investigational (Specific phase for gliomas not provided) |common_side_effects=Varies; for leukemia treatment includes fluid retention, nausea, muscle cra..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Gleevec_(Imatinib)"